| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium channel activity | 3.51e-07 | 52 | 176 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | phosphatase binding | AKAP6 DAB2IP CACNA1B ANK1 TSC2 ITGA1 MAST2 STRN PIK3R2 PPP1R9B IRS2 SIGLEC11 MYO16 | 6.57e-07 | 264 | 176 | 13 | GO:0019902 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | PHACTR2 ANK1 MAP1A CLASP1 RTCB CLIP2 SYNM SPTB SPTBN1 SPTBN2 APC2 GRIA2 MAST2 KIF7 TTBK2 TRIM32 STARD9 CGN SCNN1A DIAPH2 PPP1R9B MYO18B LYN TOR1AIP1 MYO16 EPB41 VCL | 1.29e-06 | 1099 | 176 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.85e-06 | 26 | 176 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.27e-05 | 17 | 176 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | AKAP6 DAB2IP CACNA1B ANK1 ITGA1 STRN PIK3R2 PPP1R9B IRS2 MYO16 | 1.78e-05 | 210 | 176 | 10 | GO:0019903 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN10A SCNN1A RIMBP2 | 4.27e-05 | 334 | 176 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A SCN2A KCNJ16 SCN9A SCN10A SCNN1A RIMBP2 | 5.52e-05 | 343 | 176 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.56e-04 | 130 | 176 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A RIMBP2 | 2.25e-04 | 459 | 176 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | sodium ion binding | 2.28e-04 | 14 | 176 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.33e-04 | 184 | 176 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | actin binding | PHACTR2 MAP1A SPTB SPTBN1 SPTBN2 CGN SCNN1A DIAPH2 PPP1R9B MYO18B MYO16 EPB41 VCL | 3.39e-04 | 479 | 176 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 4.98e-04 | 18 | 176 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 5.03e-04 | 42 | 176 | 4 | GO:0051721 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.03e-04 | 42 | 176 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A RIMBP2 | 7.98e-04 | 525 | 176 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A RIMBP2 | 8.12e-04 | 526 | 176 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.18e-04 | 171 | 176 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A SCN2A KCNJ16 SCN9A SCN10A SCNN1A RIMBP2 | 8.88e-04 | 465 | 176 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 9.16e-04 | 22 | 176 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.18e-03 | 182 | 176 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.51e-03 | 26 | 176 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.69e-03 | 308 | 176 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | nodal binding | 2.09e-03 | 8 | 176 | 2 | GO:0038100 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.08e-05 | 89 | 175 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.31e-05 | 100 | 175 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.18e-05 | 105 | 175 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.23e-05 | 144 | 175 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | response to pain | 7.11e-05 | 51 | 175 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 7.16e-05 | 2 | 175 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 7.16e-05 | 2 | 175 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 7.16e-05 | 2 | 175 | 2 | GO:1900123 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 4.49e-09 | 9 | 173 | 5 | GO:0014731 | |
| GeneOntologyCellularComponent | axon | DAB2IP CACNA1B RELN ANK1 MAP1A LRFN3 SPTBN1 GRIA2 TSC2 PLXND1 TENM3 SCN1A SCN2A SCN9A SCN10A NAV1 PPP1R9B RIMBP2 UNC13C PUM1 PCDH9 DYNC1H1 ACAP3 | 1.32e-06 | 891 | 173 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | cell cortex | ARHGAP32 ANK1 CLASP1 CLIP2 SPTB SPTBN1 SPTBN2 FAM110A SCNN1A PPP1R9B RIMBP2 UNC13C DYNC1H1 EPB41 | 2.71e-06 | 371 | 173 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | sodium channel complex | 3.70e-06 | 29 | 173 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.91e-06 | 17 | 173 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.22e-05 | 129 | 173 | 8 | GO:0030863 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SHANK1 CACNA1B INPP4A SPTB LRFN3 SPTBN1 SPTBN2 GRIA2 TSC2 PLXND1 ZDHHC8 INA TENM3 SCN2A SCN10A RNF10 IQSEC1 ELAVL1 RIMBP2 LYN | 1.48e-05 | 817 | 173 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | AKAP6 CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A | 1.67e-05 | 378 | 173 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | postsynaptic specialization | SHANK1 ARHGAP32 MAP1A INPP4A LRFN3 SPTBN1 GRIA2 TSC2 STRN INA GLRA2 RNF10 IQSEC1 PPP1R9B LYN | 2.00e-05 | 503 | 173 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | presynaptic active zone | 2.33e-05 | 141 | 173 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | cation channel complex | AKAP6 CACNA1B RYR3 CACNA2D4 SCN1A SCN2A KCNJ16 SCN9A SCN10A SCNN1A | 2.73e-05 | 235 | 173 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 EPPK1 SYNM SPTBN2 ASH1L STRN FAT2 SCN1A SCN2A CGN SSX2IP PPP1R9B LYN PCDH1 PCDH9 VCL | 3.40e-05 | 591 | 173 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | postsynapse | SHANK1 ARHGAP32 ANK1 MAP1A INPP4A SPTB LRFN3 SPTBN1 SPTBN2 APC2 GRIA2 TSC2 ZDHHC8 STRN RAB3GAP1 INA GLRA2 RNF10 IQSEC1 ELAVL1 PPP1R9B LYN | 3.67e-05 | 1018 | 173 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | spectrin | 4.51e-05 | 9 | 173 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | axon initial segment | 9.15e-05 | 29 | 173 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | main axon | 9.70e-05 | 89 | 173 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | postsynaptic density | SHANK1 ARHGAP32 MAP1A INPP4A LRFN3 SPTBN1 GRIA2 TSC2 STRN INA RNF10 IQSEC1 PPP1R9B | 1.02e-04 | 451 | 173 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 EPPK1 CLASP1 SYNM SPTBN2 ASH1L ITGA1 MAST2 STRN FAT2 PIK3R2 SCN1A SCN2A CGN SSX2IP PPP1R9B LYN PCDH1 PCDH9 VCL | 1.74e-04 | 976 | 173 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | asymmetric synapse | SHANK1 ARHGAP32 MAP1A INPP4A LRFN3 SPTBN1 GRIA2 TSC2 STRN INA RNF10 IQSEC1 PPP1R9B | 1.77e-04 | 477 | 173 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | sarcolemma | 1.89e-04 | 190 | 173 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGAP32 ACACA SPTB SPTBN1 SPTBN2 APC2 CGN SCNN1A DIAPH2 PPP1R9B MYO18B MYO16 EPB41 VCL | 3.24e-04 | 576 | 173 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | synaptic membrane | SHANK1 ANK1 LRFN3 GRIA2 STRN TENM3 OTOF SCN1A GLRA2 SCN2A SCN10A RNF10 PPP1R9B UNC13C | 3.65e-04 | 583 | 173 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | sarcoplasm | 3.76e-04 | 114 | 173 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | dendritic microtubule | 4.04e-04 | 4 | 173 | 2 | GO:1901588 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | SHANK1 ARHGAP32 MAP1A INPP4A LRFN3 SPTBN1 GRIA2 TSC2 STRN INA RNF10 IQSEC1 PPP1R9B | 4.29e-04 | 523 | 173 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | transmembrane transporter complex | AKAP6 CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A | 4.29e-04 | 523 | 173 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | myofibril | 4.66e-04 | 273 | 173 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | transporter complex | AKAP6 CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN1A GLRA2 SCN2A KCNJ16 SCN9A SCN10A SCNN1A | 6.86e-04 | 550 | 173 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.18e-04 | 290 | 173 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 8.25e-04 | 88 | 173 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.06e-03 | 93 | 173 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.11e-03 | 94 | 173 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | sarcomere | 1.13e-03 | 249 | 173 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | Z disc | 1.63e-03 | 151 | 173 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL6A1 EPPK1 ANK1 MAP1A CLASP1 CLIP2 SYNM SPTBN1 APC2 FAM110A RYR3 KIF7 INA TRIM32 SCN1A DIAPH2 NAV1 MYO18B DYNC1H1 VCL | 1.84e-03 | 1179 | 173 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | excitatory synapse | 1.97e-03 | 107 | 173 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL6A1 EPPK1 ANK1 MAP1A CLASP1 CLIP2 SYNM SPTBN1 APC2 FAM110A RYR3 KIF7 INA TRIM32 SCN1A DIAPH2 NAV1 MYO18B DYNC1H1 VCL | 1.99e-03 | 1187 | 173 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.21e-03 | 277 | 173 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | dendritic spine neck | 2.36e-03 | 9 | 173 | 2 | GO:0044326 | |
| GeneOntologyCellularComponent | intercalated disc | 2.44e-03 | 68 | 173 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | I band | 2.63e-03 | 166 | 173 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.16e-03 | 73 | 173 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 4.02e-03 | 78 | 173 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | transcription export complex | 4.26e-03 | 12 | 173 | 2 | GO:0000346 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.47e-03 | 185 | 173 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | neuron projection membrane | 4.80e-03 | 82 | 173 | 4 | GO:0032589 | |
| MousePheno | abnormal CNS synaptic transmission | SHANK1 CACNA1B ARHGAP32 RELN INPP4A LRFN3 SPTBN2 GRIA2 TSC2 ZDHHC8 RYR3 ADRA1D RAB3GAP1 OTOF SCN1A GLRA2 SCN2A APLNR SCN9A RNF10 IQSEC1 PPP1R9B RIMBP2 UNC13C PUM1 BAIAP3 PCDH9 | 1.84e-06 | 985 | 142 | 27 | MP:0002206 |
| MousePheno | abnormal synaptic physiology | SHANK1 CACNA1B ARHGAP32 RELN CLIP2 INPP4A LRFN3 SPTBN2 GRIA2 TSC2 ZDHHC8 RYR3 ADRA1D RAB3GAP1 OTOF SCN1A GLRA2 SCN2A APLNR SCN9A RNF10 IQSEC1 PPP1R9B RIMBP2 UNC13C PUM1 BAIAP3 PCDH9 | 3.15e-06 | 1076 | 142 | 28 | MP:0021009 |
| MousePheno | abnormal synaptic transmission | SHANK1 CACNA1B ARHGAP32 RELN INPP4A LRFN3 SPTBN2 GRIA2 TSC2 ZDHHC8 RYR3 ADRA1D RAB3GAP1 OTOF SCN1A GLRA2 SCN2A APLNR SCN9A RNF10 IQSEC1 PPP1R9B RIMBP2 UNC13C PUM1 BAIAP3 PCDH9 | 8.63e-06 | 1070 | 142 | 27 | MP:0003635 |
| MousePheno | Purkinje cell degeneration | 1.79e-05 | 81 | 142 | 7 | MP:0000876 | |
| MousePheno | tricuspid valve atresia | 8.24e-05 | 9 | 142 | 3 | MP:0006123 | |
| MousePheno | abnormal left renal vein morphology | 1.02e-04 | 2 | 142 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 1.02e-04 | 2 | 142 | 2 | MP:0011323 | |
| MousePheno | decreased cellular hemoglobin content | 1.17e-04 | 10 | 142 | 3 | MP:0008956 | |
| MousePheno | abnormal miniature inhibitory postsynaptic currents | 1.78e-04 | 52 | 142 | 5 | MP:0009435 | |
| MousePheno | abnormal cellular hemoglobin content | 2.11e-04 | 12 | 142 | 3 | MP:0008954 | |
| MousePheno | decreased brain size | SPTB TERT PTHLH OTC AIFM1 SCN1A RNF10 NAV1 PPP1R9B DYNC1H1 VCL | 2.11e-04 | 295 | 142 | 11 | MP:0000774 |
| MousePheno | absent long-term depression | 2.28e-04 | 30 | 142 | 4 | MP:0001899 | |
| MousePheno | abnormal Purkinje cell morphology | 2.36e-04 | 204 | 142 | 9 | MP:0000877 | |
| MousePheno | abnormal gait | SHANK1 DOCK3 CACNA1B RELN SPTBN2 APC2 PTHLH LEFTY2 LEFTY1 AIFM1 STARD9 SCN1A RNF10 LYN DYNC1H1 | 2.61e-04 | 520 | 142 | 15 | MP:0001406 |
| MousePheno | spherocytosis | 2.72e-04 | 13 | 142 | 3 | MP:0002812 | |
| MousePheno | abnormal habituation to a novel odor | 3.05e-04 | 3 | 142 | 2 | MP:0011622 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 3.05e-04 | 3 | 142 | 2 | MP:0011311 | |
| MousePheno | seizures | ARHGAP32 SPTBN2 APC2 GRIA2 OTC AIFM1 SCN1A SCN9A RNF10 PPP1R9B SENP2 BAIAP3 | 3.06e-04 | 360 | 142 | 12 | MP:0002064 |
| MousePheno | abnormal cerebellar Purkinje cell layer | 4.11e-04 | 220 | 142 | 9 | MP:0000875 | |
| MousePheno | abnormal single cell response | 4.18e-04 | 35 | 142 | 4 | MP:0003463 | |
| MousePheno | abnormal kidney iron level | 4.27e-04 | 15 | 142 | 3 | MP:0008742 | |
| MousePheno | increased kidney iron level | 4.27e-04 | 15 | 142 | 3 | MP:0010375 | |
| MousePheno | abnormal brain size | SPTB TERT PTHLH OTC AIFM1 PIK3R2 SCN1A RNF10 NAV1 PPP1R9B DYNC1H1 VCL | 4.42e-04 | 375 | 142 | 12 | MP:0000771 |
| Domain | Na_channel_asu | 1.46e-06 | 10 | 174 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 1.46e-06 | 10 | 174 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 1.46e-06 | 10 | 174 | 4 | PF06512 | |
| Domain | Spectrin_bsu | 3.16e-06 | 4 | 174 | 3 | IPR016343 | |
| Domain | Channel_four-helix_dom | 1.47e-05 | 57 | 174 | 6 | IPR027359 | |
| Domain | - | 1.47e-05 | 57 | 174 | 6 | 1.20.120.350 | |
| Domain | Na_trans_cytopl | 1.56e-05 | 6 | 174 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.56e-05 | 6 | 174 | 3 | IPR024583 | |
| Domain | IQ_motif_EF-hand-BS | 2.10e-05 | 90 | 174 | 7 | IPR000048 | |
| Domain | IQ | 2.61e-05 | 93 | 174 | 7 | PS50096 | |
| Domain | LRDF | 8.63e-05 | 2 | 174 | 2 | IPR003942 | |
| Domain | Ion_trans_dom | 9.62e-05 | 114 | 174 | 7 | IPR005821 | |
| Domain | Ion_trans | 9.62e-05 | 114 | 174 | 7 | PF00520 | |
| Domain | VWA | 1.72e-04 | 56 | 174 | 5 | PF00092 | |
| Domain | SPEC | 2.13e-04 | 32 | 174 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.13e-04 | 32 | 174 | 4 | IPR018159 | |
| Domain | C2 | 3.01e-04 | 137 | 174 | 7 | SM00239 | |
| Domain | - | 4.79e-04 | 148 | 174 | 7 | 2.60.40.150 | |
| Domain | G8_domain | 5.11e-04 | 4 | 174 | 2 | IPR019316 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | PS51484 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | SM01225 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | PF10162 | |
| Domain | IQ | 5.25e-04 | 71 | 174 | 5 | PF00612 | |
| Domain | Munc13_dom-2 | 8.47e-04 | 5 | 174 | 2 | IPR014772 | |
| Domain | MHD2 | 8.47e-04 | 5 | 174 | 2 | PS51259 | |
| Domain | Protocadherin | 8.47e-04 | 5 | 174 | 2 | PF08374 | |
| Domain | Munc13_subgr_dom-2 | 8.47e-04 | 5 | 174 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 8.47e-04 | 5 | 174 | 2 | PF10540 | |
| Domain | Protocadherin | 8.47e-04 | 5 | 174 | 2 | IPR013585 | |
| Domain | C2_dom | 8.81e-04 | 164 | 174 | 7 | IPR000008 | |
| Domain | IQ | 9.59e-04 | 81 | 174 | 5 | SM00015 | |
| Domain | VWFA | 1.01e-03 | 82 | 174 | 5 | PS50234 | |
| Domain | VWA | 1.13e-03 | 84 | 174 | 5 | SM00327 | |
| Domain | Spectrin | 1.23e-03 | 23 | 174 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.23e-03 | 23 | 174 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.23e-03 | 23 | 174 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.23e-03 | 23 | 174 | 3 | IPR001589 | |
| Domain | LCCL | 1.26e-03 | 6 | 174 | 2 | PS50820 | |
| Domain | LCCL | 1.26e-03 | 6 | 174 | 2 | SM00603 | |
| Domain | LCCL | 1.26e-03 | 6 | 174 | 2 | PF03815 | |
| Domain | LCCL | 1.26e-03 | 6 | 174 | 2 | IPR004043 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 2.170.130.20 | |
| Domain | Rho_GTPase_activation_prot | 1.39e-03 | 88 | 174 | 5 | IPR008936 | |
| Domain | Munc13_1 | 1.76e-03 | 7 | 174 | 2 | IPR014770 | |
| Domain | MHD1 | 1.76e-03 | 7 | 174 | 2 | PS51258 | |
| Domain | DUF1041 | 1.76e-03 | 7 | 174 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.76e-03 | 7 | 174 | 2 | IPR010439 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.46e-10 | 31 | 120 | 8 | M877 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.81e-07 | 121 | 120 | 9 | M872 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.01e-06 | 10 | 120 | 4 | MM15112 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB3 COL6A1 RELN ANK1 CLASP1 SPTB SPTBN1 SPTBN2 ITGA1 PLXND1 PIK3R2 SCN1A SCN2A SCN9A SCN10A IRS2 LYN | 7.21e-06 | 575 | 120 | 17 | M29853 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB3 COL6A1 RELN ANK1 SPTB SPTBN1 SPTBN2 PLXND1 PIK3R2 IRS2 LYN | 1.39e-05 | 261 | 120 | 11 | MM15676 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | SHANK1 ACACA MTHFD1L GRIA2 TSC2 ADRA1D PIK3R2 SCN1A SCN2A SCN9A SCN10A AADAT | 6.82e-05 | 367 | 120 | 12 | M48346 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.49e-04 | 32 | 120 | 4 | M27455 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 2.61e-04 | 67 | 120 | 5 | M39630 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.95e-04 | 38 | 120 | 4 | MM14969 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 3.96e-04 | 41 | 120 | 4 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 4.35e-04 | 42 | 120 | 4 | M41821 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 4.47e-04 | 18 | 120 | 3 | M22001 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP DOCK3 EPPK1 ACACA MTHFD1L SPEG KTI12 TSC2 FAM110A PLXND1 MAST2 ZDHHC8 SBNO2 TPCN1 NHSL1 NUAK1 RRP12 DIAPH2 NAV1 SENP2 IRS2 DENND5A ZC3H7B PUM1 ABTB2 DYNC1H1 PKN3 SDHA RASAL1 | 4.38e-13 | 1105 | 177 | 29 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 PHACTR2 ACACA CLASP1 RTCB SPTBN1 TSC2 PTPN21 MAST2 RGS12 NHSL1 INA FAM171A2 STARD9 CGN SSX2IP RNF10 IQSEC1 NAV1 IRS2 CRYBG3 PUM1 ABTB2 EPB41 AQR | 2.43e-12 | 861 | 177 | 25 | 36931259 |
| Pubmed | DAB2IP SHANK1 ARHGAP32 CLASP1 CLIP2 ARGLU1 SPTBN1 SPTBN2 APC2 GRIA2 TSC2 KIF7 STRN INA FAM171A2 EIF4A1 KCNJ16 DIAPH2 IQSEC1 NAV1 ELAVL1 PPP1R9B RIMBP2 DYNC1H1 RASAL1 | 2.68e-11 | 963 | 177 | 25 | 28671696 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP SHANK1 ARHGAP32 MAP1A SPTBN1 SPTBN2 GRIA2 STRN INA IQSEC1 PPP1R9B PCDH1 DYNC1H1 RASAL1 | 2.26e-10 | 281 | 177 | 14 | 28706196 |
| Pubmed | DAB2IP ARHGAP32 EPPK1 CLASP1 CLIP2 ARGLU1 MTHFD1L APC2 KIAA1549 GRIA2 TRIM32 STARD9 IQSEC1 CCDC15 PPP1R9B VCL | 8.12e-10 | 430 | 177 | 16 | 32581705 | |
| Pubmed | SHANK1 GPD2 ARHGAP32 MAP1A CLASP1 RTCB CLIP2 ARGLU1 INPP4A SPTB SPTBN1 SPTBN2 KIAA1549 GRIA2 NHSL1 STRN INA SCN2A IQSEC1 NAV1 ELAVL1 PPP1R9B RIMBP2 PCDH1 DYNC1H1 SDHA RASAL1 VCL | 1.01e-09 | 1431 | 177 | 28 | 37142655 | |
| Pubmed | EPPK1 ACACA RTCB MTHFD1L SPTBN1 SPTBN2 NOC3L INA EIF4A1 RRP12 CGN ELAVL1 SCAF11 PUM1 NXF1 DYNC1H1 AQR SDHA VCL | 1.20e-09 | 653 | 177 | 19 | 22586326 | |
| Pubmed | 4.02e-09 | 13 | 177 | 5 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 9.65e-09 | 6 | 177 | 4 | 23652591 | |
| Pubmed | DAB2IP SHANK1 DOCK3 CACNA1B ARHGAP32 ACACA MAP1A SPTBN1 GRIA2 NHSL1 STRN RAB3GAP1 INA FAM171A2 SCN1A RNF10 IQSEC1 NAV1 PPP1R9B CRYBG3 EPB41 SDHA RASAL1 | 2.06e-08 | 1139 | 177 | 23 | 36417873 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP ARHGAP32 SPTBN2 DCBLD1 KIAA1549 ZDHHC8 RGS12 CEMIP2 INA FAM171A2 USP32 NAV1 STX7 LYN PCDH1 EPB41 | 4.18e-08 | 569 | 177 | 16 | 30639242 |
| Pubmed | AKAP6 SHANK1 DOCK3 RELN CLIP2 SYNM ARGLU1 SPTB SPTBN1 SPTBN2 APC2 ASH1L TSC2 PNISR RYR3 OTOF TRIM32 EIF4A1 USP32 RNF10 CCDC15 PRMT2 DYNC1H1 SDHA | 4.29e-08 | 1285 | 177 | 24 | 35914814 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANK1 ACACA CLASP1 MTHFD1L SPEG SPTBN1 SPTBN2 RGS12 RYR3 RRP12 USP32 SCN9A DIAPH2 IRS2 PUM1 | 4.51e-08 | 497 | 177 | 15 | 36774506 |
| Pubmed | DAB2IP SHANK1 ARHGAP32 SPTBN1 SPTBN2 GRIA2 INA KCNJ16 IQSEC1 DYNC1H1 RASAL1 | 7.55e-08 | 251 | 177 | 11 | 27507650 | |
| Pubmed | DAB2IP SHANK1 DOCK3 SPTB SPTBN1 GRIA2 ZDHHC8 STRN SCN1A IQSEC1 | 7.65e-08 | 197 | 177 | 10 | 36604605 | |
| Pubmed | 8.01e-08 | 9 | 177 | 4 | 16382098 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCHCR1 ARHGAP32 ACACA MTHFD1L SPTBN2 NOC3L MAST2 RGS12 KIF7 IBTK STRN EIF2D INA CGN SSX2IP LYN DYNC1H1 EPB41 VCL | 8.54e-08 | 853 | 177 | 19 | 28718761 |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 22449024 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.33e-07 | 10 | 177 | 4 | 22159418 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 GPD2 RELN MAP1A CLASP1 RTCB ARGLU1 SPTBN1 SPTBN2 PNISR ZSCAN29 INA TRIM32 EIF4A1 RRP12 IQSEC1 ELAVL1 NXF1 DYNC1H1 AQR C1orf174 | 1.72e-07 | 1082 | 177 | 21 | 38697112 |
| Pubmed | DAB2IP CLASP1 SPEG TENM3 STARD9 RRP12 NAV1 SENP2 RIMBP2 PUM1 BAIAP3 DYNC1H1 AQR | 1.93e-07 | 407 | 177 | 13 | 12693553 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 GPD2 EPPK1 RTCB ARGLU1 SPTBN2 KIF7 INA AIFM1 EIF4A1 RRP12 CGN ELAVL1 STX7 PUM1 LYN TOR1AIP1 NXF1 DYNC1H1 AQR | 3.13e-07 | 1024 | 177 | 20 | 24711643 |
| Pubmed | 3.68e-07 | 130 | 177 | 8 | 12421765 | ||
| Pubmed | 4.47e-07 | 13 | 177 | 4 | 18796539 | ||
| Pubmed | DAB2IP GPD2 ARHGAP32 SPTBN1 SPTBN2 NOC3L KIAA1549 PTPN21 CEMIP2 KIF7 NHSL1 FAM171A2 AIFM1 RRP12 CGN SSX2IP PPP1R9B SENP2 CRYBG3 PUM1 | 4.56e-07 | 1049 | 177 | 20 | 27880917 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 22260870 | ||
| Pubmed | Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | 5.16e-07 | 4 | 177 | 3 | 38172636 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 21412925 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 27606670 | ||
| Pubmed | CLASP1 KIAA1549 TSC2 MAST2 KIF7 STRN TRIM32 CGN SSX2IP NAV1 PPP1R9B IRS2 PUM1 | 5.44e-07 | 446 | 177 | 13 | 24255178 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 9.03e-07 | 101 | 177 | 7 | 24613305 | |
| Pubmed | 1.27e-06 | 153 | 177 | 8 | 10718198 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 8812438 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP ARHGAP32 PHACTR2 ARGLU1 SPTBN1 SPTBN2 FAM110A CEMIP2 NHSL1 TENM3 CGN PCDH1 EPB41 VCL | 1.36e-06 | 565 | 177 | 14 | 25468996 |
| Pubmed | PGS1 THNSL1 MAST2 CEMIP2 SBNO2 IBTK EIF2D TRIM32 EIF4A1 DIAPH2 CRYBG3 DENND5A ZC3H7B NXF1 AQR | 1.36e-06 | 650 | 177 | 15 | 38777146 | |
| Pubmed | DAB2IP ARHGAP32 PHACTR2 ACACA CCDC28A CEMIP2 NHSL1 FAM171A2 TENM3 PIK3R2 STX7 SDHA | 1.90e-06 | 421 | 177 | 12 | 36976175 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | THOC1 EPPK1 RTCB SYNM ARGLU1 SPTBN1 SPTBN2 MKRN2 NOC3L EIF4A1 RRP12 CGN NAV1 ELAVL1 PPP1R9B SCAF11 LYN NXF1 DYNC1H1 AQR SDHA | 1.91e-06 | 1257 | 177 | 21 | 36526897 |
| Pubmed | SCFD2 SYNM ARGLU1 MTHFD1L SPTBN1 SPTBN2 NOC3L KIAA1549 CEMIP2 KIF7 RAB3GAP1 FAM171A2 AIFM1 PIK3R2 RRP12 SSX2IP SENP2 CRYBG3 STX7 TOR1AIP1 AQR SDHA VCL | 2.19e-06 | 1487 | 177 | 23 | 33957083 | |
| Pubmed | 2.95e-06 | 20 | 177 | 4 | 18723693 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.13e-06 | 231 | 177 | 9 | 16452087 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TICRR ANK1 ACACA SPTBN2 TSC2 OTC ADRA1D AIFM1 MCUR1 PKHD1 LYN NXF1 DYNC1H1 RBM43 SDHA | 6.11e-06 | 736 | 177 | 15 | 29676528 |
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 37709743 | ||
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 7.12e-06 | 8 | 177 | 3 | 25609709 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SCFD2 GPD2 THNSL1 SYNM ARGLU1 MTHFD1L TSC2 MRPL57 IBTK STRN OTC RAB3GAP1 AIFM1 RRP12 SSX2IP MCUR1 NAV1 ELAVL1 SENP2 CRYBG3 TOR1AIP1 SDHA | 8.24e-06 | 1496 | 177 | 22 | 32877691 |
| Pubmed | 8.27e-06 | 197 | 177 | 8 | 31620119 | ||
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 1.04e-05 | 27 | 177 | 4 | 33417976 | |
| Pubmed | 1.10e-05 | 147 | 177 | 7 | 16959763 | ||
| Pubmed | 1.27e-05 | 209 | 177 | 8 | 36779422 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 GPD2 ACACA RTCB MTHFD1L SPTBN1 NOC3L MAST2 AIFM1 STARD9 EIF4A1 RRP12 ELAVL1 MYO18B PUM1 TOR1AIP1 NXF1 DYNC1H1 AQR SDHA VCL | 1.30e-05 | 1425 | 177 | 21 | 30948266 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 ARHGAP32 EPPK1 MAP1A APC2 KDM5D PRR14 PIK3R2 SCN1A SCN10A DYNC1H1 | 1.41e-05 | 430 | 177 | 11 | 35044719 |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.51e-05 | 10 | 177 | 3 | 15345741 | |
| Pubmed | 1.51e-05 | 10 | 177 | 3 | 20602612 | ||
| Pubmed | 1.60e-05 | 104 | 177 | 6 | 9205841 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.78e-05 | 361 | 177 | 10 | 26167880 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EPPK1 RTCB SPTBN1 MKRN2 NOC3L PNISR EIF4A1 RRP12 ELAVL1 SCAF11 ZC3H7B PUM1 NXF1 DYNC1H1 AQR | 1.80e-05 | 807 | 177 | 15 | 22681889 |
| Pubmed | AKAP6 KIAA1549 PLXND1 CEMIP2 TPCN1 IBTK NUAK1 RNF10 SCAF11 KDM7A ZC3H7B ACAP3 | 1.89e-05 | 529 | 177 | 12 | 14621295 | |
| Pubmed | Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway. | 2.08e-05 | 11 | 177 | 3 | 31504727 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.08e-05 | 11 | 177 | 3 | 17607528 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.58e-05 | 2 | 177 | 2 | 10827969 | |
| Pubmed | Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis. | 2.58e-05 | 2 | 177 | 2 | 26830532 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 32745796 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 19694741 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.58e-05 | 2 | 177 | 2 | 1317301 | |
| Pubmed | Human alpha-synemin interacts directly with vinculin and metavinculin. | 2.58e-05 | 2 | 177 | 2 | 18028034 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24603075 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31439038 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 20056823 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 10053005 | ||
| Pubmed | Mutation analysis of human LEFTY A and LEFTY B genes in children with Ivemark syndrome. | 2.58e-05 | 2 | 177 | 2 | 11100524 | |
| Pubmed | Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. | 2.58e-05 | 2 | 177 | 2 | 11427698 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.58e-05 | 2 | 177 | 2 | 15249644 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24147624 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 36444616 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 2.58e-05 | 2 | 177 | 2 | 26884715 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 30693367 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15163412 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16060676 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29649454 | ||
| Pubmed | Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. | 2.58e-05 | 2 | 177 | 2 | 20171171 | |
| Pubmed | Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit. | 2.58e-05 | 2 | 177 | 2 | 8159688 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 9496783 | ||
| Pubmed | A functional role of LEFTY during progesterone therapy for endometrial carcinoma. | 2.58e-05 | 2 | 177 | 2 | 29268772 | |
| Pubmed | Integrin alpha1 localization in murine central and peripheral nervous system. | 2.58e-05 | 2 | 177 | 2 | 9603370 | |
| Pubmed | Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. | 2.58e-05 | 2 | 177 | 2 | 27667160 | |
| Pubmed | Lipid-binding role of betaII-spectrin ankyrin-binding domain. | 2.58e-05 | 2 | 177 | 2 | 17716929 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 17591625 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12130521 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 2.58e-05 | 2 | 177 | 2 | 16111501 | |
| Pubmed | Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma. | 2.58e-05 | 2 | 177 | 2 | 30798076 | |
| Pubmed | Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways. | 2.58e-05 | 2 | 177 | 2 | 33409963 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29230527 | ||
| Pubmed | Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. | 2.58e-05 | 2 | 177 | 2 | 11130074 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 33096315 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31014431 | ||
| Pubmed | Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. | 2.58e-05 | 2 | 177 | 2 | 17038673 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26311622 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29286065 | ||
| Pubmed | Structural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrin. | 2.58e-05 | 2 | 177 | 2 | 17520478 | |
| Pubmed | Isolation, characterization, and function of EBAF/LEFTY B: role in infertility. | 2.58e-05 | 2 | 177 | 2 | 21401636 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21377452 | ||
| Interaction | TOP3B interactions | THOC1 DAB2IP DOCK3 EPPK1 ACACA MTHFD1L SPEG SPTB SPTBN2 MKRN2 KTI12 TSC2 FAM110A PLXND1 MAST2 ZDHHC8 SBNO2 TPCN1 NHSL1 IBTK NUAK1 EIF4A1 RRP12 SSX2IP DIAPH2 NAV1 ELAVL1 PPP1R9B SENP2 IRS2 DENND5A ZC3H7B PUM1 LYN ABTB2 DYNC1H1 PKN3 SDHA RASAL1 | 1.17e-10 | 1470 | 171 | 39 | int:TOP3B |
| Interaction | RHOB interactions | DAB2IP ARHGAP32 PHACTR2 EPPK1 MAP1A CCDC28A SPTBN1 SPTBN2 MKRN2 ASH1L DCBLD1 KIAA1549 TSC2 ITGA1 ZDHHC8 CEMIP2 FAM171A2 TENM3 PIK3R2 RRP12 USP32 DIAPH2 IQSEC1 ELAVL1 IRS2 STX7 LYN PKN3 | 5.32e-10 | 840 | 171 | 28 | int:RHOB |
| Interaction | YWHAH interactions | DAB2IP TICRR ARHGAP32 PHACTR2 EPPK1 CLASP1 RTCB SPEG SPTBN1 TSC2 PTPN21 MAST2 RGS12 KIF7 NHSL1 INA FAM171A2 NUAK1 TRIM32 STARD9 CGN SSX2IP RNF10 NAV1 ELAVL1 PPP1R9B IRS2 CRYBG3 PUM1 EPB41 AQR VCL | 8.34e-10 | 1102 | 171 | 32 | int:YWHAH |
| Interaction | YWHAG interactions | DAB2IP TICRR ARHGAP32 PHACTR2 CLASP1 RTCB SPEG SPTBN1 TSC2 PTPN21 MAST2 RGS12 KIF7 NHSL1 INA FAM171A2 NUAK1 TRIM32 STARD9 CGN SSX2IP IQSEC1 NAV1 ELAVL1 PPP1R9B SCAF11 IRS2 PUM1 DYNC1H1 EPB41 AQR SDHA VCL | 4.54e-09 | 1248 | 171 | 33 | int:YWHAG |
| Interaction | YWHAZ interactions | DAB2IP TICRR ARHGAP32 CLASP1 CLIP2 SPEG SPTBN1 SPTBN2 TSC2 PTPN21 MAST2 TERT THAP9 RGS12 NHSL1 STRN INA FAM171A2 TRIM32 STARD9 PIK3R2 CGN SSX2IP NAV1 PPP1R9B SCAF11 IRS2 PUM1 NXF1 DYNC1H1 EPB41 SDHA VCL | 1.75e-08 | 1319 | 171 | 33 | int:YWHAZ |
| Interaction | AGAP2 interactions | DAB2IP SHANK1 MAP1A SPTBN1 SPTBN2 GRIA2 STRN INA IQSEC1 PPP1R9B PCDH1 DYNC1H1 RASAL1 | 2.99e-08 | 210 | 171 | 13 | int:AGAP2 |
| Interaction | YWHAQ interactions | DAB2IP TICRR ARHGAP32 PHACTR2 EPPK1 ACACA CLASP1 RTCB SPEG SPTB TSC2 MAST2 TERT RGS12 NHSL1 INA FAM171A2 TRIM32 STARD9 PIK3R2 CGN SSX2IP NAV1 IRS2 PUM1 DYNC1H1 EPB41 SDHA VCL | 6.89e-08 | 1118 | 171 | 29 | int:YWHAQ |
| Interaction | YWHAB interactions | DAB2IP TICRR ARHGAP32 CLASP1 SPEG SPTBN1 TSC2 PTPN21 MAST2 RGS12 NHSL1 FAM171A2 NUAK1 TRIM32 STARD9 PIK3R2 CGN SSX2IP USP32 NAV1 ELAVL1 PPP1R9B IRS2 PUM1 DYNC1H1 EPB41 SDHA | 1.23e-07 | 1014 | 171 | 27 | int:YWHAB |
| Interaction | DLG4 interactions | DAB2IP SHANK1 DOCK3 ARHGAP32 MAP1A ARGLU1 SPTBN1 GRIA2 ZDHHC8 INA FAM171A2 KCNJ16 IQSEC1 ELAVL1 PPP1R9B LYN RASAL1 | 2.95e-07 | 449 | 171 | 17 | int:DLG4 |
| Interaction | SLC6A4 interactions | DAB2IP ARHGAP32 EPPK1 CLASP1 CLIP2 ARGLU1 MTHFD1L APC2 KIAA1549 GRIA2 TRIM32 STARD9 IQSEC1 CCDC15 PPP1R9B VCL | 1.04e-06 | 437 | 171 | 16 | int:SLC6A4 |
| Interaction | SYNGAP1 interactions | DAB2IP SHANK1 DOCK3 ARHGAP32 MAP1A SPTBN1 SPTBN2 GRIA2 STRN IQSEC1 PPP1R9B DYNC1H1 RASAL1 | 2.31e-06 | 307 | 171 | 13 | int:SYNGAP1 |
| Interaction | SCN11A interactions | 6.35e-06 | 15 | 171 | 4 | int:SCN11A | |
| Interaction | RHOD interactions | ARHGAP32 CCDC28A SPTB SPTBN1 SPTBN2 DCBLD1 KIAA1549 ITGA1 CEMIP2 RAB3GAP1 PIK3R2 DIAPH2 SENP2 STX7 LYN TOR1AIP1 EPB41 | 7.87e-06 | 572 | 171 | 17 | int:RHOD |
| Interaction | EFNB1 interactions | DAB2IP EPHB3 RELN TSC2 CEACAM21 FAM171A2 PIK3R2 USP32 STX7 LYN PKN3 | 1.19e-05 | 255 | 171 | 11 | int:EFNB1 |
| Interaction | RYK interactions | EPHB3 DCBLD1 CEACAM21 FAM171A2 AIFM1 ELAVL1 PCDH1 PCDH9 NXF1 DYNC1H1 | 1.39e-05 | 212 | 171 | 10 | int:RYK |
| Interaction | KCTD13 interactions | SHANK1 GPD2 ARHGAP32 MAP1A CLASP1 RTCB CLIP2 ARGLU1 INPP4A SPTB SPTBN1 SPTBN2 KIAA1549 GRIA2 NHSL1 STRN INA SCN2A IQSEC1 NAV1 ELAVL1 PPP1R9B RIMBP2 PCDH1 DYNC1H1 SDHA RASAL1 VCL | 1.74e-05 | 1394 | 171 | 28 | int:KCTD13 |
| Interaction | RHOF interactions | ARHGAP32 EPPK1 SPTBN1 SPTBN2 DCBLD1 KIAA1549 KTI12 ITGA1 ZDHHC8 CEMIP2 FAM171A2 PIK3R2 DIAPH2 ELAVL1 LYN TOR1AIP1 NXF1 EPB41 | 1.75e-05 | 673 | 171 | 18 | int:RHOF |
| Interaction | SIRT7 interactions | EPPK1 ACACA RTCB MTHFD1L SPTBN1 SPTBN2 NOC3L INA EIF4A1 RRP12 CGN ELAVL1 SCAF11 PUM1 NXF1 DYNC1H1 AQR SDHA VCL | 1.92e-05 | 744 | 171 | 19 | int:SIRT7 |
| Interaction | CEP135 interactions | CCHCR1 ARHGAP32 SYNM KIF7 IBTK INA CGN SSX2IP NAV1 CCDC15 TOR1AIP1 | 2.17e-05 | 272 | 171 | 11 | int:CEP135 |
| Interaction | TNIK interactions | SHANK1 ARHGAP32 CLASP1 SPTBN1 SPTBN2 GRIA2 KIF7 STRN INA IQSEC1 RIMBP2 LYN DYNC1H1 | 2.34e-05 | 381 | 171 | 13 | int:TNIK |
| Interaction | MAPRE3 interactions | 2.80e-05 | 230 | 171 | 10 | int:MAPRE3 | |
| Interaction | CX3CL1 interactions | 3.10e-05 | 71 | 171 | 6 | int:CX3CL1 | |
| Interaction | CACNA1D interactions | 4.66e-05 | 24 | 171 | 4 | int:CACNA1D | |
| Interaction | CDC42 interactions | ARHGAP32 ACACA CCDC28A SPTBN1 SPTBN2 MKRN2 DCBLD1 KIAA1549 GRIA2 ITGA1 PNISR ZDHHC8 CEMIP2 TENM3 AIFM1 PIK3R2 CGN SSX2IP DIAPH2 ELAVL1 PPP1R9B SENP2 STX7 LYN TOR1AIP1 SDHA | 5.20e-05 | 1323 | 171 | 26 | int:CDC42 |
| Interaction | ANK3 interactions | 5.65e-05 | 201 | 171 | 9 | int:ANK3 | |
| Interaction | FBXO22 interactions | ANK1 ACACA CLASP1 MTHFD1L SPEG SPTBN1 SPTBN2 RGS12 RYR3 RRP12 USP32 SCN9A DIAPH2 IRS2 PUM1 | 5.95e-05 | 540 | 171 | 15 | int:FBXO22 |
| Interaction | TIAM1 interactions | 6.58e-05 | 205 | 171 | 9 | int:TIAM1 | |
| Interaction | RAC3 interactions | DAB2IP ARHGAP32 SPTBN1 SPTBN2 DCBLD1 KIAA1549 ITGA1 ZDHHC8 CEMIP2 FAM171A2 TENM3 PIK3R2 DIAPH2 STX7 LYN TOR1AIP1 | 7.85e-05 | 619 | 171 | 16 | int:RAC3 |
| Interaction | SHANK3 interactions | SHANK1 COL6A1 MAP1A SPTBN1 SPTBN2 KIF7 INA FAM171A2 IQSEC1 ELAVL1 PRMT2 PPP1R9B DYNC1H1 SDHA | 8.91e-05 | 496 | 171 | 14 | int:SHANK3 |
| Interaction | RHOG interactions | DAB2IP ARHGAP32 ACACA CCDC28A MTHFD1L SPTBN1 SPTBN2 DCBLD1 KIAA1549 ITGA1 ZDHHC8 CEMIP2 MRPL57 PIK3R2 DIAPH2 SENP2 STX7 TOR1AIP1 EPB41 SDHA | 9.43e-05 | 910 | 171 | 20 | int:RHOG |
| Interaction | PDSS2 interactions | 1.01e-04 | 29 | 171 | 4 | int:PDSS2 | |
| Interaction | SCN1A interactions | 1.01e-04 | 29 | 171 | 4 | int:SCN1A | |
| Interaction | RHOQ interactions | ARHGAP32 SPTBN1 SPTBN2 KIAA1549 ITGA1 ZDHHC8 CEMIP2 FAM171A2 PIK3R2 DIAPH2 ELAVL1 STX7 LYN | 1.06e-04 | 442 | 171 | 13 | int:RHOQ |
| Interaction | ARF6 interactions | ARHGAP32 EPPK1 SPTBN1 SPTBN2 MKRN2 KIAA1549 ZDHHC8 CEMIP2 PIK3R2 IQSEC1 STX7 LYN TOR1AIP1 DYNC1H1 EPB41 | 1.42e-04 | 584 | 171 | 15 | int:ARF6 |
| Interaction | CAV1 interactions | ARHGAP32 SPTBN1 SPTBN2 KIAA1549 TSC2 ITGA1 ZDHHC8 CEMIP2 STRN FAM171A2 PIK3R2 RRP12 STX7 LYN NXF1 EPB41 VCL | 1.49e-04 | 724 | 171 | 17 | int:CAV1 |
| Interaction | DLGAP1 interactions | 1.55e-04 | 180 | 171 | 8 | int:DLGAP1 | |
| Interaction | YWHAE interactions | DAB2IP TICRR ARHGAP32 CLASP1 TSC2 FAM110A PTPN21 MAST2 RGS12 INA NUAK1 TRIM32 PIK3R2 CGN SSX2IP NAV1 PPP1R9B SCAF11 IRS2 PUM1 DYNC1H1 EPB41 SDHA VCL | 1.60e-04 | 1256 | 171 | 24 | int:YWHAE |
| Interaction | BMI1 interactions | CCHCR1 ACACA RTCB ARGLU1 SPTBN1 TSC2 RYR3 AIFM1 RRP12 ELAVL1 SCAF11 IRS2 PUM1 NXF1 DYNC1H1 AQR | 1.61e-04 | 659 | 171 | 16 | int:BMI1 |
| Interaction | KALRN interactions | 1.69e-04 | 96 | 171 | 6 | int:KALRN | |
| Interaction | FMR1 interactions | THOC1 CLASP1 SPTBN1 MKRN2 APC2 INA FAM171A2 SSX2IP DIAPH2 IQSEC1 ELAVL1 ZC3H7B PUM1 DYNC1H1 | 2.00e-04 | 536 | 171 | 14 | int:FMR1 |
| Interaction | NALCN interactions | 2.04e-04 | 14 | 171 | 3 | int:NALCN | |
| Interaction | KTI12 interactions | 2.13e-04 | 35 | 171 | 4 | int:KTI12 | |
| Interaction | EFNB2 interactions | 2.22e-04 | 143 | 171 | 7 | int:EFNB2 | |
| Interaction | DYNLT1 interactions | 2.24e-04 | 241 | 171 | 9 | int:DYNLT1 | |
| Interaction | CACNA1B interactions | 2.66e-04 | 37 | 171 | 4 | int:CACNA1B | |
| Interaction | SFN interactions | ARHGAP32 MAP1A CLASP1 SPTBN1 TSC2 MAST2 RGS12 INA FAM171A2 TRIM32 CGN NAV1 IRS2 CRYBG3 PUM1 VCL | 2.79e-04 | 692 | 171 | 16 | int:SFN |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.48e-07 | 9 | 108 | 4 | 1203 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.13e-06 | 7 | 108 | 3 | 1113 | |
| GeneFamily | Intermediate filaments Type IV | 5.22e-04 | 6 | 108 | 2 | 611 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.48e-03 | 206 | 108 | 6 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.54e-03 | 10 | 108 | 2 | 830 | |
| GeneFamily | Non-clustered protocadherins | 2.24e-03 | 12 | 108 | 2 | 21 | |
| GeneFamily | Ankyrin repeat domain containing | 3.32e-03 | 242 | 108 | 6 | 403 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | DAB2IP CACNA1B MAP1A SPTBN1 APC2 TSC2 ZSCAN29 INA PIK3R2 GLRA2 SCN2A NAV1 RIMBP2 IRS2 MYO16 ACAP3 | 1.69e-07 | 488 | 173 | 16 | M39104 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 DOCK3 RELN ANK1 INPP4A SPEG APC2 TATDN2 KIAA1549 GRIA2 TSC2 FAT2 INA NUAK1 SCN1A GLRA2 SCN2A CGN SCN9A NAV1 RIMBP2 PCDH1 PCDH9 EPB41 | 3.05e-07 | 1106 | 173 | 24 | M39071 |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 7.72e-06 | 200 | 173 | 9 | M6254 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 1.17e-05 | 45 | 173 | 5 | M1369 | |
| Coexpression | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN | 1.17e-05 | 45 | 173 | 5 | MM576 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.41e-05 | 79 | 173 | 6 | M7102 | |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP EPHB3 COL6A1 ABHD15 EPPK1 ANK1 SYNM INPP4A APC2 ASH1L TP53I3 KIAA1549 TSC2 MMEL1 NUAK1 IQSEC1 RIMBP2 BAIAP3 ABTB2 EPB41 ACAP3 SMAD6 | 1.49e-05 | 1201 | 173 | 22 | M4391 |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN | 4.48e-05 | 11 | 173 | 3 | M27966 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DAB2IP ARHGAP32 CLIP2 SPTBN1 PTPN21 PTHLH RGS12 CEMIP2 FAT2 PRDM10 TRIM32 AIFM1 CGN SCNN1A PCDH1 VCL SMAD6 | 4.61e-05 | 843 | 173 | 17 | M2356 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-09 | 184 | 176 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-09 | 184 | 176 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-09 | 184 | 176 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SPTBN2 FREM1 TENM3 SCN2A KCNJ16 PKHD1 UNC13C KDM7A ABTB2 RASAL1 | 5.74e-09 | 194 | 176 | 10 | 04bfc555743f7d8821439d05ae442d15e9886c59 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SPTBN2 FREM1 TENM3 SCN2A KCNJ16 PKHD1 UNC13C KDM7A ABTB2 RASAL1 | 5.74e-09 | 194 | 176 | 10 | 69bff17df4a760ccf081cf52ff04af02c14f448d |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-09 | 198 | 176 | 10 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.82e-08 | 186 | 176 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.38e-08 | 188 | 176 | 9 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-08 | 189 | 176 | 9 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.31e-08 | 191 | 176 | 9 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-08 | 193 | 176 | 9 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.94e-08 | 198 | 176 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-07 | 171 | 176 | 8 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-07 | 171 | 176 | 8 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-07 | 173 | 176 | 8 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-07 | 178 | 176 | 8 | 2c581a338bf33dbd2be9abe87d0a84f97dfb546f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-07 | 178 | 176 | 8 | 5caeffb70cbb868586bd260b44ccd3751bbfa615 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-07 | 178 | 176 | 8 | afc3220e2319cb38d59307db1b793a3915e1d5c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-07 | 178 | 176 | 8 | 4ff23a0bb20c4373db14bfaad18b5fa5c7c78e76 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-07 | 186 | 176 | 8 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-07 | 187 | 176 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-07 | 189 | 176 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-07 | 190 | 176 | 8 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-07 | 191 | 176 | 8 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-06 | 192 | 176 | 8 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.00e-06 | 192 | 176 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 193 | 176 | 8 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 193 | 176 | 8 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 193 | 176 | 8 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 193 | 176 | 8 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-06 | 194 | 176 | 8 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 196 | 176 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 197 | 176 | 8 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 198 | 176 | 8 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 159 | 176 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 159 | 176 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.65e-06 | 172 | 176 | 7 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.86e-06 | 173 | 176 | 7 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 177 | 176 | 7 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 179 | 176 | 7 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 179 | 176 | 7 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.60e-06 | 180 | 176 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.88e-06 | 181 | 176 | 7 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.88e-06 | 181 | 176 | 7 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.88e-06 | 181 | 176 | 7 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.17e-06 | 182 | 176 | 7 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.17e-06 | 182 | 176 | 7 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.47e-06 | 183 | 176 | 7 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-06 | 187 | 176 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.75e-06 | 187 | 176 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 187 | 176 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.01e-05 | 188 | 176 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 176 | 7 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 176 | 7 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 190 | 176 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 190 | 176 | 7 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 190 | 176 | 7 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 190 | 176 | 7 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 191 | 176 | 7 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-05 | 191 | 176 | 7 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 191 | 176 | 7 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-05 | 191 | 176 | 7 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 192 | 176 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 1.16e-05 | 192 | 176 | 7 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 193 | 176 | 7 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.20e-05 | 193 | 176 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 193 | 176 | 7 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 193 | 176 | 7 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 194 | 176 | 7 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 194 | 176 | 7 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 194 | 176 | 7 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 194 | 176 | 7 | f93f5148b136819d87faef89707dbaba07d6c2b5 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.28e-05 | 195 | 176 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 195 | 176 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | PND03-Endothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 196 | 176 | 7 | a529681d822a95dd1980b7b1c71dc61aaf0baecd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 196 | 176 | 7 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 196 | 176 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 196 | 176 | 7 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 197 | 176 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 197 | 176 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 197 | 176 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 197 | 176 | 7 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 131 | 176 | 6 | 537a79ea2b5d6b3dc0444570b1acbceda59b0d7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 198 | 176 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 199 | 176 | 7 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 199 | 176 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-05 | 200 | 176 | 7 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 200 | 176 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-05 | 200 | 176 | 7 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-05 | 200 | 176 | 7 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 145 | 176 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.84e-05 | 149 | 176 | 6 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-05 | 151 | 176 | 6 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-05 | 151 | 176 | 6 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 152 | 176 | 6 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 152 | 176 | 6 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 154 | 176 | 6 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 3.81e-05 | 157 | 176 | 6 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| Drug | N-methyl-DL-aspartic acid | SHANK1 EPHB3 CACNA1B ARHGAP32 RELN LRFN3 GRIA2 RYR3 TPCN1 ADRA1D EIF2D CACNA2D4 TRIM32 AIFM1 PIK3R2 GLRA2 CGN KCNJ16 SCN9A SCNN1A PPP1R9B PKN3 | 7.13e-09 | 655 | 175 | 22 | CID000004376 |
| Drug | lamotrigine | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 SCN2A SCN9A SCN10A SCNN1A NAV1 | 2.25e-08 | 116 | 175 | 10 | CID000003878 |
| Drug | gabapentin | CACNA1B GRIA2 RYR3 TPCN1 CACNA2D4 CGN SCN9A SCN10A SCNN1A AADAT | 7.75e-07 | 169 | 175 | 10 | CID000003446 |
| Drug | phenytoin | CACNA1B COL6A1 CYP2C8 PTHLH RYR3 TPCN1 CACNA2D4 SCN2A SCN9A SCN10A SCNN1A | 1.09e-06 | 219 | 175 | 11 | CID000001775 |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | INPP4A SPTBN1 SPTBN2 PLXND1 PTPN21 SBNO2 STRN SENP2 ZC3H7B TOR1AIP1 | 2.83e-06 | 195 | 175 | 10 | 6706_DN |
| Drug | sulindac sulfone; Up 200; 50uM; MCF7; HG-U133A | 3.11e-06 | 197 | 175 | 10 | 314_UP | |
| Drug | MDL 28170 | 3.60e-06 | 54 | 175 | 6 | CID000072430 | |
| Drug | riluzole | 8.40e-06 | 174 | 175 | 9 | CID000005070 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.10e-05 | 180 | 175 | 9 | 5950_UP | |
| Drug | mexiletine | 1.17e-05 | 66 | 175 | 6 | CID000004178 | |
| Drug | isradipine | 1.23e-05 | 100 | 175 | 7 | CID000003784 | |
| Drug | glutamate | GPD2 CACNA1B RELN SPTBN2 GRIA2 RYR3 OTC ADRA1D EIF2D CACNA2D4 TRIM32 AIFM1 GLRA2 CGN KCNJ16 SCN9A SCNN1A NAV1 PPP1R9B AADAT PKN3 | 1.67e-05 | 962 | 175 | 21 | CID000000611 |
| Drug | loperamide | 1.70e-05 | 105 | 175 | 7 | CID000003954 | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 1.93e-05 | 193 | 175 | 9 | 7059_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.01e-05 | 194 | 175 | 9 | 3747_DN | |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 4459_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 3717_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.45e-05 | 199 | 175 | 9 | 2297_UP | |
| Drug | procaine | 2.49e-05 | 153 | 175 | 8 | CID000004914 | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.55e-05 | 200 | 175 | 9 | 7002_DN | |
| Drug | tetradotoxin | CACNA1B GRIA2 ADRA1D CACNA2D4 INA TRIM32 GLRA2 SCN2A SCN9A SCN10A SCNN1A NAV1 PKN3 | 2.86e-05 | 428 | 175 | 13 | CID000020382 |
| Drug | PbTx-1 | 5.15e-05 | 27 | 175 | 4 | CID006437089 | |
| Drug | bepridil | 5.50e-05 | 126 | 175 | 7 | CID000002351 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 5.97e-05 | 173 | 175 | 8 | 2105_UP | |
| Drug | d 42 | 7.04e-05 | 11 | 175 | 3 | CID005288018 | |
| Drug | maleimide | 7.04e-05 | 131 | 175 | 7 | CID000010935 | |
| Drug | dimethyl adipimidate | 7.91e-05 | 30 | 175 | 4 | CID000025738 | |
| Drug | NSC7524 | 8.52e-05 | 182 | 175 | 8 | CID000005657 | |
| Drug | scriptaid; Up 200; 10uM; MCF7; HT_HG-U133A | 9.20e-05 | 184 | 175 | 8 | 6901_UP | |
| Drug | S 105 | 9.33e-05 | 12 | 175 | 3 | CID000031154 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 9.92e-05 | 186 | 175 | 8 | 6987_UP | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.92e-05 | 186 | 175 | 8 | 3178_UP | |
| Drug | AC1L1DW2 | 9.92e-05 | 186 | 175 | 8 | CID000002532 | |
| Drug | verapamil | CACNA1B CYP2C8 RYR3 TPCN1 LEFTY2 LEFTY1 ADRA1D CACNA2D4 KCNJ16 SCN9A SCN10A SCNN1A PKN3 | 1.13e-04 | 490 | 175 | 13 | CID000002520 |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.19e-04 | 191 | 175 | 8 | 7538_UP | |
| Drug | ADPribulose | 1.21e-04 | 13 | 175 | 3 | CID000197570 | |
| Drug | lercanidipine | 1.24e-04 | 63 | 175 | 5 | CID000065866 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.33e-04 | 194 | 175 | 8 | 6195_UP | |
| Drug | mibefradil | 1.34e-04 | 64 | 175 | 5 | CID000060662 | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.38e-04 | 195 | 175 | 8 | 5115_UP | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A | 1.38e-04 | 195 | 175 | 8 | 1243_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; PC3; HT_HG-U133A | 1.38e-04 | 195 | 175 | 8 | 4011_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.38e-04 | 195 | 175 | 8 | 5834_UP | |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A | 1.42e-04 | 196 | 175 | 8 | 283_UP | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 175 | 8 | 6585_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 175 | 8 | 4446_DN | |
| Drug | AC1NPPZW | 1.46e-04 | 103 | 175 | 6 | CID005183170 | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.48e-04 | 197 | 175 | 8 | 3686_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 197 | 175 | 8 | 3528_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 197 | 175 | 8 | 7231_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.48e-04 | 197 | 175 | 8 | 2163_UP | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 1.53e-04 | 198 | 175 | 8 | 5064_DN | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.53e-04 | 198 | 175 | 8 | 3805_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 1.53e-04 | 198 | 175 | 8 | 6145_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 3565_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 5772_UP | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 1.58e-04 | 199 | 175 | 8 | 264_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 6153_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 6312_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 3333_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.58e-04 | 199 | 175 | 8 | 7217_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 200 | 175 | 8 | 7329_UP | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; HL60; HT_HG-U133A | 1.64e-04 | 200 | 175 | 8 | 3111_UP | |
| Drug | pyraclofos | 1.71e-04 | 106 | 175 | 6 | CID000093460 | |
| Drug | hex-BCH | 1.75e-04 | 3 | 175 | 2 | CID003036943 | |
| Drug | betaCCB | 1.75e-04 | 3 | 175 | 2 | CID000128618 | |
| Drug | chlordene | 1.75e-04 | 3 | 175 | 2 | CID000019519 | |
| Drug | mono-(2-ethylhexyl)phthalate | ANK1 SPTBN2 KDM5D PRKAG3 ADRA1D MMEL1 AIFM1 SCN1A KCNJ16 SCN9A PKHD1 RIMBP2 IRS2 RASAL1 VCL | 1.79e-04 | 658 | 175 | 15 | ctd:C016599 |
| Drug | 4-AP | 1.80e-04 | 258 | 175 | 9 | CID000001727 | |
| Drug | benzocaine | 1.83e-04 | 37 | 175 | 4 | CID000002337 | |
| Drug | sipatrigine | 1.83e-04 | 37 | 175 | 4 | CID000060803 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.02e-07 | 10 | 167 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.73e-07 | 12 | 167 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 7.09e-07 | 4 | 167 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 6.69e-06 | 22 | 167 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.46e-05 | 9 | 167 | 3 | C3502809 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.66e-05 | 152 | 167 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 3.18e-05 | 2 | 167 | 2 | C4551549 | |
| Disease | Ciliopathies | 3.96e-05 | 110 | 167 | 6 | C4277690 | |
| Disease | epilepsy (implicated_via_orthology) | 4.17e-05 | 163 | 167 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.88e-05 | 13 | 167 | 3 | C0751122 | |
| Disease | Intellectual Disability | AKAP6 CACNA1B INPP4A APC2 ASH1L GRIA2 KIF7 SCN1A IQSEC1 PUM1 DYNC1H1 | 5.19e-05 | 447 | 167 | 11 | C3714756 |
| Disease | Primary Erythermalgia | 9.52e-05 | 3 | 167 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 9.52e-05 | 3 | 167 | 2 | C1833661 | |
| Disease | reticulocyte count | CCHCR1 PGS1 ANK1 CLASP1 SPTB ASH1L FAM110A ITGA1 MAST2 SBNO2 STRN USP32 RNF10 IRS2 STX7 BAIAP3 EPB41 | 9.67e-05 | 1045 | 167 | 17 | EFO_0007986 |
| Disease | Schizophrenia | SHANK1 CACNA1B ARHGAP32 RELN SPTBN2 GRIA2 PTPN21 ZDHHC8 RGS12 SBNO2 CEACAM21 NAV1 PPP1R9B MYO16 SDHA | 1.59e-04 | 883 | 167 | 15 | C0036341 |
| Disease | Elliptocytosis found | 1.90e-04 | 4 | 167 | 2 | C0427480 | |
| Disease | Hereditary elliptocytosis | 1.90e-04 | 4 | 167 | 2 | cv:C0013902 | |
| Disease | periodontitis | 2.92e-04 | 223 | 167 | 7 | EFO_0000649 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 3.15e-04 | 5 | 167 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 3.15e-04 | 5 | 167 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 3.15e-04 | 5 | 167 | 2 | C0221409 | |
| Disease | Elliptocytosis, Hereditary | 4.71e-04 | 6 | 167 | 2 | C0013902 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 4.71e-04 | 6 | 167 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | AKAP6 DOCK3 GPD2 COL6A1 ARHGAP32 MTHFD1L CFAP299 SCN2A RIMBP2 TOR1AIP1 PCDH9 SMAD6 | 4.75e-04 | 673 | 167 | 12 | HP_0000539 |
| Disease | obsolete_red blood cell distribution width | PGS1 ANK1 CLASP1 SPTB MKRN2 ZNF407 FREM3 STRN EIF4A1 MCUR1 RNF10 IRS2 ZC3H7B STX7 LYN CDCA5 MYO16 SMAD6 | 6.54e-04 | 1347 | 167 | 18 | EFO_0005192 |
| Disease | Seizure, Febrile, Simple | 6.56e-04 | 7 | 167 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 6.56e-04 | 7 | 167 | 2 | C0751057 | |
| Disease | Congenital Pain Insensitivity | 6.56e-04 | 7 | 167 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 6.56e-04 | 7 | 167 | 2 | C0020075 | |
| Disease | Alzheimer's disease (is_marker_for) | 6.80e-04 | 257 | 167 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Heart Failure, Diastolic | 8.57e-04 | 33 | 167 | 3 | C1135196 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 8.72e-04 | 8 | 167 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 8.72e-04 | 8 | 167 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 8.72e-04 | 8 | 167 | 2 | C0338479 | |
| Disease | Hereditary spherocytosis | 8.72e-04 | 8 | 167 | 2 | C0037889 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 8.72e-04 | 8 | 167 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 8.72e-04 | 8 | 167 | 2 | C0438414 | |
| Disease | lymphatic vessel endothelial hyaluronic acid receptor 1 measurement | 8.72e-04 | 8 | 167 | 2 | EFO_0020539 | |
| Disease | Myoclonic Absence Epilepsy | 8.72e-04 | 8 | 167 | 2 | C0393703 | |
| Disease | Global developmental delay | 9.81e-04 | 133 | 167 | 5 | C0557874 | |
| Disease | Febrile Convulsions | 1.12e-03 | 9 | 167 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 1.12e-03 | 9 | 167 | 2 | C0014550 | |
| Disease | triple-negative breast cancer | 1.39e-03 | 10 | 167 | 2 | EFO_0005537 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.39e-03 | 10 | 167 | 2 | C0917800 | |
| Disease | Autism Spectrum Disorders | 1.40e-03 | 85 | 167 | 4 | C1510586 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.44e-03 | 145 | 167 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.51e-03 | 40 | 167 | 3 | C0598589 | |
| Disease | age at onset, Myopia | 1.67e-03 | 150 | 167 | 5 | EFO_0004847, HP_0000545 | |
| Disease | cortical surface area measurement | SCFD2 TICRR RELN SPTBN1 PLXND1 IRAG1 MAST2 PTHLH NHSL1 STRN INA NUAK1 KCNJ16 PKHD1 NAV1 PPP1R9B MYO16 | 1.68e-03 | 1345 | 167 | 17 | EFO_0010736 |
| Disease | Myoclonic Astatic Epilepsy | 1.69e-03 | 11 | 167 | 2 | C0393702 | |
| Disease | white matter microstructure measurement | 1.78e-03 | 390 | 167 | 8 | EFO_0005674 | |
| Disease | suicide behaviour measurement | 1.86e-03 | 43 | 167 | 3 | EFO_0006882 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 2.02e-03 | 12 | 167 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | potassium measurement | 2.12e-03 | 45 | 167 | 3 | EFO_0009283 | |
| Disease | Pancreatic Neoplasm | 2.55e-03 | 100 | 167 | 4 | C0030297 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.71e-03 | 49 | 167 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of pancreas | 2.73e-03 | 102 | 167 | 4 | C0346647 | |
| Disease | reticulocyte measurement | PGS1 ANK1 CLASP1 SPTB ASH1L FAM110A ITGA1 PTHLH SBNO2 USP32 IRS2 STX7 BAIAP3 EPB41 | 2.74e-03 | 1053 | 167 | 14 | EFO_0010700 |
| Disease | urate measurement, bone density | AKAP6 DAB2IP CYP2C8 MTHFD1L THAP9 FREM1 STRN NAV1 MYO16 RASAL1 | 2.87e-03 | 619 | 167 | 10 | EFO_0003923, EFO_0004531 |
| Disease | hemoglobin A1 measurement | 2.95e-03 | 520 | 167 | 9 | EFO_0007629 | |
| Disease | calcium measurement | 3.18e-03 | 628 | 167 | 10 | EFO_0004838 | |
| Disease | MMR-related febrile seizures | 3.19e-03 | 15 | 167 | 2 | EFO_0006519 | |
| Disease | Tinnitus, response to cisplatin | 3.19e-03 | 15 | 167 | 2 | GO_0072718, HP_0000360 | |
| Disease | human papilloma virus infection, oropharynx cancer | 3.39e-03 | 53 | 167 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | Epilepsy | 3.47e-03 | 109 | 167 | 4 | C0014544 | |
| Disease | Small cell carcinoma of lung | 3.57e-03 | 54 | 167 | 3 | C0149925 | |
| Disease | Neuralgia, Supraorbital | 3.63e-03 | 16 | 167 | 2 | C0038870 | |
| Disease | omega-3 polyunsaturated fatty acid measurement, diet measurement | 3.63e-03 | 16 | 167 | 2 | EFO_0008111, EFO_0010119 | |
| Disease | Neuralgia | 3.63e-03 | 16 | 167 | 2 | C0027796 | |
| Disease | Synostotic Posterior Plagiocephaly | 3.63e-03 | 16 | 167 | 2 | C1833340 | |
| Disease | Neuralgia, Atypical | 3.63e-03 | 16 | 167 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.63e-03 | 16 | 167 | 2 | C0234249 | |
| Disease | Craniosynostosis, Type 1 | 3.63e-03 | 16 | 167 | 2 | C4551902 | |
| Disease | Acrocephaly | 3.63e-03 | 16 | 167 | 2 | C0030044 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.63e-03 | 16 | 167 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.63e-03 | 16 | 167 | 2 | C0423711 | |
| Disease | Trigonocephaly | 3.63e-03 | 16 | 167 | 2 | C0265535 | |
| Disease | Scaphycephaly | 3.63e-03 | 16 | 167 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 3.63e-03 | 16 | 167 | 2 | C2931150 | |
| Disease | Paroxysmal Nerve Pain | 3.63e-03 | 16 | 167 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.63e-03 | 16 | 167 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.63e-03 | 16 | 167 | 2 | C0751371 | |
| Disease | Metopic synostosis | 3.63e-03 | 16 | 167 | 2 | C1860819 | |
| Disease | Neuralgia, Vidian | 3.63e-03 | 16 | 167 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.63e-03 | 16 | 167 | 2 | C0393706 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.08e-03 | 447 | 167 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | retinopathy | 4.10e-03 | 17 | 167 | 2 | EFO_0003839 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.10e-03 | 17 | 167 | 2 | C2936862 | |
| Disease | S-adenosylhomocysteine measurement | 4.10e-03 | 17 | 167 | 2 | EFO_0010531 | |
| Disease | Huntington Disease | 4.10e-03 | 17 | 167 | 2 | C0020179 | |
| Disease | Brachycephaly | 4.10e-03 | 17 | 167 | 2 | C0221356 | |
| Disease | dental caries | 4.32e-03 | 187 | 167 | 5 | EFO_0003819 | |
| Disease | cortical thickness | AKAP6 RELN SPTBN1 SPTBN2 PLXND1 VIT IRAG1 MAST2 NHSL1 STRN NUAK1 PKHD1 NAV1 MYO16 | 4.48e-03 | 1113 | 167 | 14 | EFO_0004840 |
| Disease | Child Behaviour Checklist assessment | 4.59e-03 | 18 | 167 | 2 | EFO_0005661 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 4.59e-03 | 18 | 167 | 2 | HP_0002373 | |
| Disease | age at first birth measurement | 4.89e-03 | 120 | 167 | 4 | EFO_0009101 | |
| Disease | response to opioid | 5.04e-03 | 61 | 167 | 3 | EFO_0008541 | |
| Disease | hematocrit | ACACA ASH1L HKDC1 ITGA1 IRAG1 MAST2 TERT TTBK2 MCUR1 PKHD1 IRS2 HCRTR2 SMAD6 | 5.09e-03 | 1011 | 167 | 13 | EFO_0004348 |
| Disease | Brugada syndrome | 5.11e-03 | 19 | 167 | 2 | MONDO_0015263 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FERTASKRASRSLDG | 531 | P11171 | |
| IRADSFSKIISSGLR | 256 | Q8N5Z0 | |
| TLRGELRFDIRKAGT | 321 | P55345 | |
| KVRRSYSRLETLGSA | 141 | Q96FF9 | |
| SSRSVLESLKRYRFG | 1506 | Q9NR48 | |
| GSDRRKLRADVTTAF | 16 | P41214 | |
| TAFSFSGVNRLRRKE | 166 | Q99708 | |
| GIKREREIFSGSLRT | 166 | Q68DQ2 | |
| AVTSSSERIRGKRRA | 41 | Q9UGI9 | |
| SALRRLEGRTSKEAQ | 1156 | O94812 | |
| DRAGAEVKSRTTLFR | 271 | O95831 | |
| RSFTEAAIRLGLERK | 451 | Q9Y2D8 | |
| RKVFGDGSRLSARLS | 16 | Q16352 | |
| GEELISFKAERRDSR | 821 | P16157 | |
| RIDIFGRTVSKRSSL | 81 | Q9NWB6 | |
| LRKTGRASDQSDFRE | 261 | Q3KPI0 | |
| KEIRRFSLTTLRNFG | 121 | P10632 | |
| VALKELSIRGDFRTT | 576 | Q13085 | |
| LSSVGTLDRKFRRDS | 566 | Q96P50 | |
| RKARTVFSDSQLSGL | 111 | Q3C1V8 | |
| RSGLLTETSSRYARK | 336 | Q9UDT6 | |
| FRASELLRSGLDRSK | 1011 | O60306 | |
| LADDVRDRITSFRKS | 51 | O60879 | |
| LARAVREAASKRSRF | 841 | Q6UB35 | |
| RGARVFLRQKSSTSL | 1906 | Q00975 | |
| TEFFRTEERIKGLSR | 416 | Q6UXT9 | |
| RSRRAFLTGLARSKG | 41 | Q9NP87 | |
| LEKASASERRFGILS | 246 | Q9H000 | |
| GRTRRISFKGALSEE | 391 | O95294 | |
| RRKESTDEILGRSAF | 336 | Q15042 | |
| SVEGSFLAVKRLRES | 151 | Q6ZSC3 | |
| FKRGSLITSLLRSRD | 256 | Q53FA7 | |
| RLSRAAKDRSATGLE | 431 | Q96PE3 | |
| AKDRSATGLERTLAI | 436 | Q96PE3 | |
| KDRLITTDSDGTYRR | 1616 | Q9HCM3 | |
| SSREKRRSADIFIAS | 56 | P35414 | |
| KLGSFSTAAEELARR | 871 | Q5VWQ8 | |
| LRIRYTEGRSKAFST | 261 | Q8NG78 | |
| ARTFNRKSGVSRAIL | 326 | Q460N3 | |
| FFTRVKSELRSRSSG | 641 | Q6ZMT4 | |
| RGLKTALVERDDFSS | 91 | P43304 | |
| DRSRGKRFSQSFREV | 71 | O75610 | |
| IDRSRAIRGEKELSS | 486 | P78559 | |
| SLQLERKRRDFTSSG | 146 | Q96AQ8 | |
| DSAREKALRGALRAS | 51 | Q96EK9 | |
| CRAGASRATLDSRFK | 516 | Q9Y6X6 | |
| KFDFSNLSSRLDGVR | 726 | Q9P2D0 | |
| ALSSSLRDLSEAGKR | 921 | Q6DN90 | |
| GRKRSFEELRALESE | 776 | Q9BY66 | |
| FRKQTELRRSGSRDV | 31 | Q8IWP9 | |
| EEAKLVSERFLTRRG | 156 | Q9Y6F6 | |
| LSRQTKRLFRSDGEL | 31 | Q5SYE7 | |
| LDSGSTKEFFRRSKI | 671 | P42262 | |
| REFRSGSSRVLITTD | 316 | P60842 | |
| RSLDTRGDLAKLFTF | 241 | Q9Y4D7 | |
| AFLGLSRKLTIRASD | 1931 | Q9NYQ8 | |
| EVDGKSRDSLRAFTR | 501 | Q9UBU9 | |
| STLRFSVLAKDRGTN | 351 | Q08174 | |
| FEKRSTRTRLSTETG | 86 | P00480 | |
| DLDRKTGVLTASRVF | 516 | Q9HC56 | |
| ILLDFTRGSRGRKNS | 161 | Q32NB8 | |
| RSKSDLSERFSRAAA | 186 | Q9BQ89 | |
| LRGFDSTDLSQRKLR | 1911 | Q5H8C1 | |
| TEEIAAFQRKRRSGS | 881 | Q2M1P5 | |
| FSRLDAGRVNTKVRS | 166 | P54753 | |
| AESRSFLLTDLASGR | 476 | Q9BTN0 | |
| SRGVAFIRFDKRSEA | 146 | Q15717 | |
| ESALASKIRRRDTLA | 466 | O75167 | |
| SHDEKLDVFSRTRGR | 376 | Q9NQV6 | |
| TARKEAFTEARGARR | 256 | P56199 | |
| DRIGSLSQRFKDTRV | 406 | Q495T6 | |
| RAEGTLRSAKSEESL | 696 | A7KAX9 | |
| RSFIAKRLSRGAVFE | 91 | Q9HAS0 | |
| KDGRRQLITSFLDSS | 751 | P78509 | |
| KSDGDRFAVTRDLTL | 1281 | P78509 | |
| LTTSGRYRARRDSLK | 801 | Q16825 | |
| RRDSLTGSSDLYKRT | 706 | Q14671 | |
| RDLASSRDDFFRTKP | 406 | A8MVW0 | |
| LRIRSSEGRQKAFST | 226 | Q8NGG1 | |
| LRIQSSEGRRKAFST | 226 | Q9UGF6 | |
| LSGKRDGTFLIRESS | 636 | O00459 | |
| DLDRGLRKRTYSLTT | 566 | Q9Y4H2 | |
| EDRLTRGRTSTESRK | 391 | O43614 | |
| LSELRREAGKDRSSV | 21 | A1A4V9 | |
| SKDSFGELSRATIRL | 116 | O95996 | |
| SDRSGFRRQLTFIKE | 1986 | O95996 | |
| VDSRLFSFSESRRIL | 841 | Q8IZD9 | |
| FAKRLAERFLTAGRT | 851 | P12109 | |
| NGFILISKRSRETGR | 896 | Q7Z3S7 | |
| ISKRSRETGRFLGEV | 901 | Q7Z3S7 | |
| EKSLSSLETRRAGEA | 201 | Q8TD31 | |
| SAKFTSIRREDRATF | 46 | Q9UHN6 | |
| GILLDSERRKSDASS | 841 | Q6IQ26 | |
| DRSRGKRFSQSFREV | 71 | O00292 | |
| FVDRAKRIDTISRAA | 411 | P23416 | |
| RESETLKGSFSLSVR | 156 | P07948 | |
| ARHRLLSGDSTEKRT | 1026 | Q6P0Q8 | |
| GIRDRESEKFRISTS | 121 | Q6UXX5 | |
| DRKITRTSFLDDAFR | 3606 | Q14204 | |
| TIFGRDLTRRDTQKA | 186 | P22680 | |
| VLSRDGSLSDKRFLF | 236 | Q8N8Z6 | |
| LTGAVRSSARLKARS | 6 | Q8IYL3 | |
| VVSDSRLAKTRDGLS | 126 | Q8IYL3 | |
| RTKSKSSSFGRIDRD | 946 | Q99590 | |
| SFTTLVAGSRSRRDL | 166 | P37088 | |
| SELRGRGDRIAKVTF | 11 | Q9HC10 | |
| LRISSLEGRAKAFST | 231 | A6NND4 | |
| LKIRTTDGRRRAFST | 231 | Q8NGC3 | |
| RIFSKRRGQDFLRAS | 431 | Q6P5Z2 | |
| DSVKGRFIISRDNSR | 81 | A0A0C4DH35 | |
| KDLGQRVSFLTRDLS | 101 | Q8WTT2 | |
| LRTDSEKRSLAESGL | 456 | Q8NEY1 | |
| RAIDRRVLDFASLKS | 186 | P0C091 | |
| GRALSRAKSRRNLDF | 431 | Q9Y3I0 | |
| RRREAFEAIKAAATS | 66 | Q9BQC6 | |
| ISKGDFRLASTTSRR | 191 | A6NDD5 | |
| DEILSSAFKLRITRG | 386 | Q9HC62 | |
| AESSRLEKRSVFLER | 681 | O15034 | |
| LEKRSVFLERSSAGQ | 686 | O15034 | |
| KRVRALLGFSSDVTD | 181 | O43815 | |
| QDELARSRKFFTGSL | 196 | Q13049 | |
| VRRRSSEKTDYRLAG | 266 | Q96M34 | |
| RSFRFSRSSEEREVK | 446 | Q93075 | |
| RSESVRRTRSKIGFG | 376 | O43541 | |
| AEARELRFRLGTSDA | 611 | O15061 | |
| LDKLRFADGSIRTSE | 496 | P31040 | |
| ISERLRTRGIFETKF | 771 | Q2TB90 | |
| KEFVARVRASSRVSG | 116 | O15400 | |
| RSVRSKLESFADIFL | 251 | Q9BWN1 | |
| FTSSRKLRRAVEFRD | 511 | Q9BWN1 | |
| SKVSFRGLRRQVSAS | 2706 | P58107 | |
| ETEERLSKVSFRGLR | 3231 | P58107 | |
| SKVSFRGLRRQVSAS | 3771 | P58107 | |
| KVSFRGLRRQVSASE | 4306 | P58107 | |
| SKRETAFSRGNERIL | 261 | Q7Z5V6 | |
| ARRSSRTSLFSFKGR | 546 | Q15858 | |
| FRAFRSSLKRVEVLD | 61 | Q13103 | |
| GERRFASIVAKRLES | 861 | Q9Y2G9 | |
| RATERFSGRVVAIKS | 71 | O60285 | |
| RGRLFVGSFRKSSRE | 2966 | P08F94 | |
| FTSLRDIAGARSLLK | 541 | Q8WU76 | |
| GESAVSLKSRSVDRR | 1941 | Q9P2P6 | |
| LASRTRDVVKSALGF | 951 | Q5JTH9 | |
| EDSIRRKGFRFSIEG | 526 | P35498 | |
| RRRSTLFLSTDAGDE | 1251 | Q9Y566 | |
| SARLFERSRIKALAD | 36 | Q01082 | |
| ESRRVRLVDTGDKFR | 1901 | Q01082 | |
| FSSFRRLDARAATEK | 471 | Q8N961 | |
| ASFRKRLTRSVADES | 1716 | Q13023 | |
| ARSTTRSLEAGVKRE | 281 | P25100 | |
| DGRKSFLTREEVLSR | 201 | Q0P6D6 | |
| RSGKLSSVIFIRDRN | 106 | Q6V702 | |
| RSKSLDSRLPRDTFE | 211 | Q9P2M7 | |
| SLRGVTEAIEKFSFR | 1181 | Q7Z460 | |
| TVDKLEDRGRTLRSS | 616 | Q7Z2Z1 | |
| TSDSLQRFLLAGRKR | 311 | O00295 | |
| VGKRTRLEEFRSDSA | 81 | Q5JTV8 | |
| FRSVRAIRIDGTDKA | 436 | Q5JTV8 | |
| GRSKRFSITRSLDDL | 651 | O14924 | |
| GSKASLRFLNVTEER | 316 | Q8NB66 | |
| DSSSARLFERSRIKA | 36 | O15020 | |
| RRIVERSSGLEFAAK | 1616 | Q15772 | |
| STRDTVLSRERGLSF | 11 | Q9H5L6 | |
| SRSQTDKLAFDVGLR | 126 | Q15413 | |
| NKGRTISRFSATRAL | 96 | Q9Y5Y9 | |
| GTDSRFSILDKRFLT | 126 | Q8N3Z0 | |
| KTREEALSGLAGSRR | 376 | Q8N5U6 | |
| RLRRYKVLGSSNSDS | 1091 | Q6IQ55 | |
| DTKARRRSFSAVAIV | 366 | Q9NPI9 | |
| SESEDSIRRKGFRFS | 526 | Q99250 | |
| SIRRKGFRFSLEGSR | 531 | Q99250 | |
| AASIKIRTDAGFTLR | 1111 | P18206 | |
| FLIDGSTSIGKRRFR | 296 | Q6UXI7 | |
| RFLSRTFALAELRKS | 31 | Q8IYQ7 | |
| GRNLLSVDFDRTTKT | 1771 | Q9P273 | |
| SARLFERSRIKALAD | 36 | P11277 | |
| TLLRDKFRDFARETG | 1726 | P11277 | |
| SVEGLSRRLKRAVSE | 26 | P12272 | |
| RRTFASSLAAVRRKA | 1161 | Q8IUG5 | |
| VFLGRRSRTKSDLSL | 756 | Q9ULQ1 | |
| FSGALRSLSLKASSR | 426 | Q9ULC8 | |
| LKRKRESERTFSRSG | 711 | Q8TF01 | |
| RERSSRFLSGLELVK | 26 | Q96S44 | |
| SFRRRSSTFTLKGQA | 426 | Q9C0G0 | |
| ADCGKSFSRSARLIR | 681 | Q8IWY8 | |
| DFSRKGVSAQRTVRL | 231 | Q96RL6 | |
| RTSIRASLTFNRGFK | 951 | O14746 | |
| LKAQSRTGRFDLETF | 206 | Q8NFA0 | |
| PEARTRFTKSTREAL | 11 | Q96FV9 | |
| RFFRSESRGAVRIKV | 451 | P49815 | |
| LDSESIRALFRKARA | 111 | Q9UGR2 | |
| LKLGTSVSERVSRFD | 111 | Q96SB3 |